Your browser doesn't support javascript.
loading
Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer.
Konstantinopoulos, Panagiotis A; Gockley, Allison A; Xiong, Niya; Krasner, Carolyn; Horowitz, Neil; Campos, Susana; Wright, Alexi A; Liu, Joyce F; Shea, Meghan; Yeku, Oladapo; Castro, Cesar; Polak, Madeline; Lee, Elizabeth K; Sawyer, Hannah; Bowes, Brittany; Moroney, John; Cheng, Su-Chun; Tayob, Nabihah; Bouberhan, Sara; Spriggs, David; Penson, Richard T; Fleming, Gini F; Nucci, Marisa R; Matulonis, Ursula A.
Affiliation
  • Konstantinopoulos PA; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Gockley AA; Brigham and Women's Hospital, Boston, Massachusetts.
  • Xiong N; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Krasner C; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Horowitz N; Brigham and Women's Hospital, Boston, Massachusetts.
  • Campos S; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Wright AA; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Liu JF; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Shea M; Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Yeku O; Massachusetts General Hospital, Boston.
  • Castro C; Massachusetts General Hospital, Boston.
  • Polak M; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lee EK; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Sawyer H; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Bowes B; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Moroney J; The University of Chicago, Chicago, Illinois.
  • Cheng SC; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Tayob N; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Bouberhan S; Massachusetts General Hospital, Boston.
  • Spriggs D; Massachusetts General Hospital, Boston.
  • Penson RT; Massachusetts General Hospital, Boston.
  • Fleming GF; The University of Chicago, Chicago, Illinois.
  • Nucci MR; Brigham and Women's Hospital, Boston, Massachusetts.
  • Matulonis UA; Dana-Farber Cancer Institute, Boston, Massachusetts.
JAMA Oncol ; 8(9): 1317-1322, 2022 09 01.
Article in En | MEDLINE | ID: mdl-35900726
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endometrial Neoplasms / B7-H1 Antigen Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Aged / Female / Humans Language: En Journal: JAMA Oncol Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endometrial Neoplasms / B7-H1 Antigen Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Aged / Female / Humans Language: En Journal: JAMA Oncol Year: 2022 Document type: Article Country of publication: United States